3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Weight Loss
1
Polycystic Ovary Syndrome
1
Overweight
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms
1
Infertility
1
Fasting
1
Breast Neoplasms
1
Interventions
Exercise
24
Metformin
19
Tirzepatide
9
Resistance Training
8
Nutrition Assessment
8
Methods
8
Diet Therapy
8
Diet
8
Counseling
7
Surveys and Questionnaires
6
semaglutide
5
Liraglutide
5
Exenatide
5
Early Intervention, Educational
5
Diet, Mediterranean
5
Caloric Restriction
5
Blood Specimen Collection
5
Educational Status
4
Bariatric Surgery
4
Vitamin D
3
Sugars
3
Standard of Care
3
Naltrexone
3
Letrozole
3
Docosahexaenoic Acids
3
Dexamethasone
3
Bupropion
3
exemestane
2
bupropion hydrochloride, naltrexone hydrochoride drug combination
2
Yoga
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Obesity
×
Diet, Vegan
×
Clear all
NCT01716429
2019-04-18
HER Health
University of South Carolina
Phase NA
Withdrawn